2014 RDCR Symposium

4th Annual RDCR Symposium

June 9-11, 2014
Bergen, Norway

About the RDCR Symposium

The 2014 Symposium was coordinated by the Traumatic Hemostasis and Oxygenation Research (THOR) Network and organized by The Norwegian Naval Operation Commando and The Norwegian Air Ambulance Foundation and is sponsored by the Norwegian Air Ambulance Foundation, the Norwegian Naval Special Operation Commando, the Royal Norwegian Navy Medical Services, the Norwegian Armed Forces Medical Services and selected industry.

THOR’s mission is to reduce the risk of death from traumatic hemorrhagic shock in the pre-hospital setting through research, education and training. There are over 200 members of the THOR Network representing 16 countries from 4 continents. Members span from military medics and civilian paramedics to academic translational and basic scientists. The multi-disciplinary nature of the Network provides an optimal mix of professionals from a diverse background that allows first responders to interact with academicians and for the scientists to educate the medics and paramedics on the latest research in the field of pre-hospital resuscitation.

2014 Conference goals

The goal of the 2014 RDCR Symposium was to focus on training methods to improve implementation of RDCR principles, to present current research in RDCR, and to provide practical information from international leaders in trauma resuscitation on their approach to RDCR.

Symposium Agenda

Agenda included 35 presentations included in the following sessions:

  • RDCR Needs Assessment
  • Optimal Resusciation Strategies
  • POC Monitoring and Terrorism Challenges
  • Endotheliopathy of Trauma
  • Plasma Efficacy and Safety
  • RDCR Concepts
  • Clinical Trials
  • Platelets and Whole Blood
  • Blood Bank Issues

Workshop

In addition to the symposium, there were workshops with the following topics discussed:

  • Hemorrhage control – practical application of a variety of tourniquets, including both traditional, junctional and clamp.
  • Decision Making (when to transfuse) – both clinical experience handover and latest monitoring equipment run down.
  • Walking donor pool and buddy transfusion – blood protocol run through and equipment run down.

 

 

 

Presentations

(drop-10 indicates that the presentation is downloadable)

RDCR Research, Development, and Acquisition within the US Department of Defense
ret COL Kenneth Bertram, MD
Principal Assistant for Acquisition
US Army Medical Research and Materiel Command
Fort Detrick, Maryland USA

drop-10 The impact of observational and retrospective research
LTC(P) Jeremy Perkins, MD FACP
Chief, Hematology-Oncology Service
US Army, Medical Corps
Walter Reed National Military Medical Center

Military RDCR Needs
CPT Andrew D Fisher, APA-C
Battalion Physician Assistant
RSTB, 75th Ranger Regiment
U.S. Army Special Operations Command

MAJ Ethan A. Miles, MD, FS
Regimental Surgeon
75th Ranger Regiment
U.S. Army Special Operations Command

Civilian RDCR Needs
Norwegian EMS

drop-10 Optimal Far-Forward Resuscitation of the Coagulopathic Patient
LTC Andrew P. Cap, MD, PhD, FACP
Chief, Coagulation and Blood Research
Director, Clinical Research Fellowship Program
US Army Institute of Surgical Research
Medical Corps, US Army
San Antonio, Texas USA

The Optimal Resuscitation Strategy for the Primary Coagulopathy of Trauma is targeted therapy
Karim Brohi, MD
Professor of Trauma Sciences
Barts and the London School of Medicine
Consultant in Trauma & Vascular surgery, Royal London Hospital
London, UK

drop-10 Pre-Hospital POC Monitory/ Goal Directed Therapy-Debate: Does it Make a Difference?
Christine Gaarder, MD, PhD
Head, Department of Traumatology
Division of Emergency and Critical Care
Oslo University Hospital
Oslo, Norway

drop-10 Challenges from terrorism: Impact on casualties – are we prepared?
Dr. Dave Sloggett, M.Sc, C.Eng., MIEE
Director, Principea Consulting Ltd
Isle of Wight, UK

Avoiding the Complications of Transfusion Support While Preserving Benefit: Applications of Pathogen Reduction Technology
Raymond Goodrich, PhD
Vice President, Scientific and Clinical Affairs
Chief Science Officer – Blood Bank Technologies
Terumo BCT, Inc.
Lakewood, Colorado USA

Pathophysiology of Endotheliopathy Trauma
Shibani Pati, MD, PhD
Assistant Professor
Blood Systems Research Institute
Department of Laboratory Medicine
University of California
San Francisco, California USA

drop-10 Treatment Strategies for the Endotheliopathy Trauma
Rosemary Kozar, MD, PhD
Professor of Surgery
Vice-Chair of Research
Memorial Hermann Hospital
University of Texas Medical School at Houston
Houston, Texas USA

drop-10 Plasma Product Differences
Øystein Flesland, MD, PhD
Head of Section
Patient Safety Reporting and Learning Systems Unit
Norwegian Knowledge Centre for the Health Services
Oslo, Norway

drop-10 Efficacy and Safety Metrics in Plasma-Based Products
Philip C. Spinella, MD FCCM
Associate Professor of Pediatrics
Division of Critical Care Medicine
Director, Critical Care Translational Research Program
Washington University School of Medicine
St. Louis, Missouri USA

drop-10 Prehospital Plasma -TXA experience – FDP in Norwegian HEMSre-Hospital Plasma/TXA Experience
Geir Arne Sunde, MD
Consultant, Anesthesiologist
Helicopter Emergency Medical Services
Haukeland University Hospital, Bergen, Norway
Researcher, Norwegian Air Ambulance Foundation
Drøbak, Norway

Pre-Hospital Plasma/TXA Experience
LTC Elon Glassberg, MD, MHA
Head, the Trauma and Combat Medicine Branch, IDF-MC
Israel Defense Forces Medical Corps

drop-10 Plasma in Pre-Hospital Setting – the French Experience and Data
Anne Sailliol, MD
Commander
French Military Blood Transfusion Center
Clamart, France

drop-10 Current Issues with Hydroxyethyl Starches
Richard Weiskopf, MD
Professor Emeritus, Department of Anesthesia
University of California, San Francisco
San Francisco, California USA

drop-10 Injectable hemostatic Adjuncts/FIINTIC Study
Marc Maegele, MD
Professor,  Department of Traumatology
and Orthopedic SurgeryAcademic  Hospital of the WittenHerdecke University
Köln, Germany

drop-10 Advancements in Tourniquets
John F. Kragh, Jr., MD
COL (Ret.), MC, US Army
Orthopedic Surgeon, Researcher
US Army Institute of Surgical Research
San Antonio, Texas, USA

Mechanisms of equal efficacy and improved safety of Octaplas in trauma patients.
Andrea Neisser-Svae, PhD
Head of IBU Intensive Care & Emergency Medicine
Octapharma

drop-10 INTRN Group Research
Christine Gaarder, MD, PhD
Head, Department of Traumatology
Division of Emergency and Critical Care
Oslo University Hospital
Oslo, Norway

drop-10 US Military Funded TXA Mechanisms Study Update
Philip C. Spinella, MD FCCM
Associate Professor of Pediatrics
Division of Critical Care Medicine
Director, Critical Care Translational Research Program
Washington University School of Medicine
St. Louis, Missouri USA

COL Allan Murdock, MD
Staff Surgeon of Trauma Critical Care
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania USA

Whole Blood Trial Updates
Geir Strandenes, MD
Senior Medical Officer
Norwegian Naval Special Operation Commando
Researcher, Department of Immunology and Transfusion Medicine
Haukeland University Hospital
Bergen, Norway

drop-10 Component vs. Whole Blood in Trauma Trial
COL Allan Murdock, MD
Staff Surgeon of Trauma Critical Care
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania USA

drop-10 Phenotypes of Postinjury Fibrinolysis : Hyperfibrinolysis, Physiologic Fibrinolysis, and Fibrinolysis Shutdown
Ernest Moore, MD
Chief of Surgery and Trauma Services
Professor
Vice Chair of the Department of Surgery
University of Colorado Health Sciences Center
Denver, Colorado  USA

Burn ICU patients as test bed for Bleeding Trials
Heather Pidcoke, MD, PhD
Research Physiologist
Deputy Task Area Manager
Coagulation and Blood Research Program
US Army Institute of Surgical Research
San Antonio, Texas USA

drop-10 Trauma-Induced Platelet dysfunction
Mitchell Jay Cohen, MD, FACS
Associate Professor of Surgery In Residence
Department of Surgery
University of California San Francisco
Associate Trauma Medical Director
Director of Trauma Research
San Francisco General Hospital
San Francisco, California USA

drop-10 Acceptable Universal Blood Products for Resuscitation
Ivar Austlid, MD
Anesthesiologist
Norwegian Naval Medical Services
Bergen, Norway

MAJ Christian Medby, MD
Norwegian Armed Forces Medical Services
Trondheim, Norway

Civilian pre-hospital platelet / whole blood plans
ret COL Donald Jenkins, MD, FACS, DMCC
Consultant, Division of Trauma, Critical Care
and General Surgery
Associate Professor of Surgery
Trauma Medical Director
Saint Mary’s Hospital, Mayo Clinic
Rochester, Minnesota USA

drop-10 What are acceptable universal blood products? prehospital vs. in hospital differences?
Paul Ness, MD
Director, Division of Transfusion Medicine
Pathology and Oncology
Johns Hopkins
Baltimore, Maryland  USA

Implementation and barriers to providing platelets and whole blood for prehospital resuscitation
James R. Stubbs, MD
Chair, Division of Transfusion Medicine
Mayo Clinic
Rochester, Minnesota USA

drop-10 Minding the Gap between prehospital and hospital transfusion support
Heidi Doughty, OBE MBA FRCP FRCPath
Consultant in Transfusion Medicine
NHS Blood and Transplant
Birmingham, UK

drop-10 Military-Civilian Collaboration in Promoting RDCR 
Eilat Shinar, MD
Director, Blood Services
Magen David Adom in Israel
Tel Aviv, Israel

drop-10 Prehospital Hemostatic Resuscitation Registry (PHRR)
Nathan White, MD
Assistant Professor, Division of Emergency Medicine
University of Washington
Seattle, Washington  USA